Xenon Pharmaceuticals Inc


Market Cap$3.22B

Compare Xenon Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Xenon Pharmaceuticals IncXenon Pharmaceuticals Inc-19.60%-25%--
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

8.9% upside

Undervalued by 8.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.22 Billion
Enterprise Value$2.69 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-2.5
Outstanding Shares65,429,711
Avg 30 Day Volume377,432


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-19.65
Price to Sales-
Price to Book Ratio5.46
Enterprise Value to Revenue20411.51
Enterprise Value to EBIT-14.48
Enterprise Value to Net Income-17
Total Debt to Enterprise0
Debt to Equity0.02

Revenue Sources

No data

ESG Score

No data

About Xenon Pharmaceuticals Inc

CEO: Simon Pimstone